Animal Antibiotics and Antimicrobials

Global Animal Antibiotics and Antimicrobials Market to Reach US$7.0 Billion by 2030

The global market for Animal Antibiotics and Antimicrobials estimated at US$5.4 Billion in the year 2024, is expected to reach US$7.0 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Tetracycline, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Penicillin segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.0% CAGR

The Animal Antibiotics and Antimicrobials market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Animal Antibiotics and Antimicrobials Market - Key Trends and Drivers Summarized

What Are Animal Antibiotics and Antimicrobials, And Why Are They Essential For Animal Health?

Animal antibiotics and antimicrobials are medicines used to prevent, treat, and control bacterial infections in animals, playing a crucial role in ensuring the health and productivity of livestock, as well as the well-being of companion animals. These drugs are essential for protecting animals from infections that could otherwise lead to severe illness or death, particularly in environments where animals are raised in close quarters, such as farms or shelters. Antibiotics target bacterial infections, while antimicrobials encompass a broader range of agents that work against bacteria, viruses, fungi, and parasites. These medicines help livestock farmers maintain the health of their herds and flocks, preventing diseases that could negatively impact meat, milk, and egg production. They are also vital in veterinary medicine for treating companion animals suffering from infections. With global demand for animal products rising and the pet care industry expanding, the need for effective antibiotics and antimicrobials has become more important than ever, making these drugs a cornerstone of modern animal health management.

How Do Antibiotics and Antimicrobials Impact Livestock Production And Companion Animal Care?

The use of antibiotics and antimicrobials in livestock production is key to maintaining herd health, productivity, and overall food security. In agriculture, these medications are primarily used to treat infections in animals, but they are also used for disease prevention and, in some cases, to promote growth by improving feed efficiency. By preventing widespread outbreaks of diseases such as bovine respiratory disease, foot rot, or mastitis in dairy cows, antibiotics help farmers avoid significant economic losses that could arise from sick or dying animals. These drugs ensure that animals remain healthy, allowing for consistent production of safe and high-quality food products. In companion animal care, antibiotics are equally important, helping pets recover from bacterial infections such as urinary tract infections, skin infections, and pneumonia. Antimicrobials can also be used to treat viral and fungal infections in both pets and livestock. As modern veterinary practices have advanced, antibiotics and antimicrobials are now formulated to be more targeted and effective, reducing recovery times and improving overall animal welfare. However, the use of these drugs is increasingly being scrutinized due to concerns over antibiotic resistance, leading to more careful management and usage in both livestock and pet care environments.

What Types of Animal Antibiotics and Antimicrobials Are Commonly Used, And How Do They Differ?

The types of antibiotics and antimicrobials used in animals vary based on the infection being treated, the species of animal, and the environment in which they live. Broad-spectrum antibiotics, such as tetracyclines, macrolides, and aminoglycosides, are commonly used in both livestock and companion animals because they are effective against a wide range of bacterial infections. For more specific bacterial infections, narrow-spectrum antibiotics like penicillin or sulfonamides are used, targeting particular types of bacteria to reduce the impact on healthy gut flora and limit the development of resistance. In addition to antibiotics, other antimicrobials such as antifungal agents, antiparasitic drugs, and antivirals are used to control a broader range of infections in animals. For example, antiparasitic agents like ivermectin are widely used in livestock to treat parasitic infestations, such as roundworms or mites. In companion animals, antifungal medications are often prescribed for skin infections like ringworm, while antivirals may be used to manage viral infections in pets, such as feline herpesvirus. The method of delivery for these drugs can also vary—oral antibiotics, injectable forms, and topical treatments are all common depending on the animal and the condition being treated. As the science of veterinary medicine continues to evolve, more precise and effective formulations are being developed to combat infections while minimizing side effects and the risk of drug resistance.

What’s Driving the Growth in the Animal Antibiotics and Antimicrobials Market?

The growth in the animal antibiotics and antimicrobials market is driven by several factors, including the rising demand for animal-derived food products, the growing pet care industry, and increasing concerns about animal welfare and health management. The global demand for meat, dairy, and eggs continues to rise as populations grow and diets shift toward higher protein consumption, particularly in emerging markets. This increase in demand puts pressure on livestock producers to maintain the health and productivity of their animals, driving the need for effective antibiotics and antimicrobials to prevent and treat infections. At the same time, the expanding pet care market, driven by rising pet ownership and the humanization of pets, has created significant demand for veterinary antibiotics to treat common infections in companion animals. Another important growth driver is the heightened focus on animal welfare and the push for better biosecurity measures on farms. As consumers become more concerned with the quality of the food they consume and the conditions in which animals are raised, there is increasing pressure on livestock producers to maintain high health standards, often through the responsible use of antibiotics and antimicrobials. However, concerns about antibiotic resistance are also shaping the market, with growing emphasis on reducing unnecessary use of antibiotics and the development of alternative treatments, such as probiotics, vaccines, and precision-targeted antimicrobials. Regulatory changes in many countries, including restrictions on the use of antibiotics for growth promotion in livestock, are also influencing how these drugs are used, creating both challenges and opportunities for innovation in the animal health sector. This evolving landscape is shaping the future of the animal antibiotics and antimicrobials market as it adapts to new health, regulatory, and consumer trends.

SCOPE OF STUDY:

The report analyzes the Animal Antibiotics and Antimicrobials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Tetracycline, Penicillin, Macrolide, Aminoglycoside, Fluoroquinolone, Sulfonamide, Other Products); Animal Type (Food-Producing Animals, Companion Animals)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Bayer AG
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Eli Lilly and Company
• Merck & Co., Inc.
• Sanofi
• Vetoquinol S.A.
• Virbac
• Zoetis, Inc.

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more